The GlaxoSmithKline bribery scandal in China has led to a 13-fold increase in the number of whistle-blowers in the company’s Chinese operation.
China’s 15-month investigation into allegations that the drugs company bribed doctors to use its products led to GSK receiving 652 whistle-blower reports from its Chinese staff in 2014; compared with 48 in 2013.
The company believes the increased whistleblowing is linked directly to the bribery investigation; which led to suspended prison sentences for senior staff and a £300M fine.
Nicola is known for her fraud, civil recovery, arbitration and business crime expertise, her experience of leading the largest financial disputes and multinational investigations and her skills in devising preventative measures and conducting internal investigations for corporates.
